Mesa Laboratories, Inc. Mesa Laboratories, Inc. Mesa Laboratories, Inc.
Our Sterilization and Disinfection Control Division manufactures and sells biological, cleaning, and chemical indicators.
Our Instruments Division designs, manufactures, and markets quality control instruments and disposable products utilized in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.
This quarterly report should be read in conjunction with the consolidated financial statements included in our annual report on Form 10-K for the year ended March 31, 2018.
As of December 31, 2018 and March 31, 2018, our financial instruments were categorized as Level 1 (inputs are quoted prices in active markets) and include cash, accounts receivable, accounts payable, accrued liabilities and short-term and long-term debt.
With the exception of long-term debt, the carrying value of these financial instruments is considered to be representative of their fair value due to the short maturity of these instruments.
During the three months ended December 31, 2018, we completed the purchase of Point Six Wireless, LLC.
We made an initial allocation of the purchase price at the date of acquisition based on our understanding of the fair value of acquired assets and assumed liabilities.
We obtained the information to make the allocation during due diligence and through the use of other information available to us.Management believes that these forward-looking statements are reasonable as and when made.
We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
We are organized into four divisions across nine physical locations.
Biological, cleaning, and chemical indicators are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
Our revenues come from three main sources – hardware and software, consumables, and services.
We typically evaluate costs and pricing annually.
Gross profit is affected by our product mix, manufacturing efficiencies, and price competition.
We are hopeful that we will have enhanced or new products and services available for sale in the coming year.Part II.